US FDA Experts Advise Industry On How To Rid Drug Manufacturing Processes Of Nitrosamines

No Uniform Checklist for Performing Risk Assessments

 
• By Joanne S. Eglovitch
  
Nitrosodimethylamine
FDA Says Manufacturers Need To Understand Nitrosamine Risks In Order To Control Them • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Compliance